DE3582466D1 - Aminoalkohol-derivate und verfahren zu ihrer herstellung. - Google Patents

Aminoalkohol-derivate und verfahren zu ihrer herstellung.

Info

Publication number
DE3582466D1
DE3582466D1 DE8585306767T DE3582466T DE3582466D1 DE 3582466 D1 DE3582466 D1 DE 3582466D1 DE 8585306767 T DE8585306767 T DE 8585306767T DE 3582466 T DE3582466 T DE 3582466T DE 3582466 D1 DE3582466 D1 DE 3582466D1
Authority
DE
Germany
Prior art keywords
production
amino alcohol
alcohol derivatives
derivatives
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8585306767T
Other languages
English (en)
Inventor
Mitsuo Masaki
Haruhiko Shinozaki
Masuru Satoh
Naoya Moritoh
Koichi Hashimoto
Toshiro Kamishiro
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Chemiphar Co Ltd
Original Assignee
Nippon Chemiphar Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Chemiphar Co Ltd filed Critical Nippon Chemiphar Co Ltd
Application granted granted Critical
Publication of DE3582466D1 publication Critical patent/DE3582466D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DE8585306767T 1984-09-28 1985-09-24 Aminoalkohol-derivate und verfahren zu ihrer herstellung. Expired - Fee Related DE3582466D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59203623A JPS6183147A (ja) 1984-09-28 1984-09-28 新規なアミノアルコール誘導体およびその製造法並びにそれを有効成分とするグルタミン酸遮断剤

Publications (1)

Publication Number Publication Date
DE3582466D1 true DE3582466D1 (de) 1991-05-16

Family

ID=16477107

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8585306767T Expired - Fee Related DE3582466D1 (de) 1984-09-28 1985-09-24 Aminoalkohol-derivate und verfahren zu ihrer herstellung.

Country Status (21)

Country Link
EP (1) EP0177245B1 (de)
JP (1) JPS6183147A (de)
KR (1) KR910002671B1 (de)
AR (1) AR242776A1 (de)
AT (1) ATE62480T1 (de)
AU (1) AU578737B2 (de)
BR (1) BR8504879A (de)
CA (1) CA1260467A (de)
CS (1) CS264332B2 (de)
DE (1) DE3582466D1 (de)
DK (1) DK167117B1 (de)
ES (1) ES8706610A1 (de)
HU (1) HU199774B (de)
IN (1) IN162767B (de)
MX (1) MX162733A (de)
MY (1) MY102921A (de)
NZ (1) NZ213628A (de)
PH (1) PH21169A (de)
RO (1) RO93388B (de)
SU (1) SU1433409A3 (de)
ZA (1) ZA857449B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5070196A (en) * 1986-02-01 1991-12-03 Nippon Chemiphar Co., Ltd. Alkylenediamine derivatives
NZ219124A (en) * 1986-02-01 1990-04-26 Nippon Chemiphar Co Alkylene diamine derivatives and pharmaceutical and insecticidal compositions thereof
JPH0314562A (ja) * 1988-04-11 1991-01-23 Nippon Chemiphar Co Ltd 新規なアルキレンジアミン誘導体およびグルタミン酸遮断剤
AU2159692A (en) * 1991-06-06 1993-01-12 G.D. Searle & Co. N-(arylethyl)-n-alkyl-2-(1-pyrrolidinyl)ethylamine derivatives for cns disorders
IT1271623B (it) * 1994-03-21 1997-06-04 Lifegroup Spa N-acilderivati di aminoalcoli con acidi monocarbossilici e bicarbossilici con attivita' neuroprotettiva nelle patologie neurologiche correlate ad eccitotossicita'
CA2231013A1 (en) * 1997-04-30 1998-10-30 Eli Lilly And Company Process for preparing benzoic acid derivative intermediates and benzothiophene pharmaceuticals
DE10251170A1 (de) * 2002-10-31 2004-05-13 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
US20040127733A1 (en) 2002-10-31 2004-07-01 Boehringer Ingelheim Pharma Gmbh & Co. Kg New beta-agonists, processes for preparing them and their use as pharmaceutical compositions
DE102004021779A1 (de) 2004-04-30 2005-11-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
DE102005052127A1 (de) 2005-10-28 2007-05-03 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue indol-haltige Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2600217A (en) * 1948-06-22 1952-06-10 American Cyanamid Co Diaryl-hydroxyalkyl-diamino compounds and preparation thereof
US3092636A (en) * 1959-10-21 1963-06-04 Upjohn Co Alpha-[2-(1-alkyleneimino) ethylamino]-alkanophenones and the corresponding alcohols
GB1200886A (en) * 1966-09-23 1970-08-05 Allen & Hanburys Ltd Phenylaminoethanol derivatives
US3517000A (en) * 1968-08-08 1970-06-23 American Home Prod Alpha-aminomethyl benzyl alcohols
FR2370472A2 (fr) * 1976-11-10 1978-06-09 Continental Pharma Amino-alcool heterocyclique, son sel et son procede de preparation
JPS6183170A (ja) * 1984-09-28 1986-04-26 Nippon Chemiphar Co Ltd 新規な1,3−オキサゾリジン−2−オン誘導体およびその製造法

Also Published As

Publication number Publication date
KR910002671B1 (ko) 1991-05-03
RO93388B (ro) 1988-01-03
EP0177245B1 (de) 1991-04-10
PH21169A (en) 1987-08-07
MY102921A (en) 1993-03-31
IN162767B (de) 1988-07-09
AU4768985A (en) 1986-04-10
BR8504879A (pt) 1986-07-22
EP0177245A2 (de) 1986-04-09
ATE62480T1 (de) 1991-04-15
EP0177245A3 (en) 1987-07-01
CA1260467A (en) 1989-09-26
CS690485A2 (en) 1988-11-15
MX162733A (es) 1991-06-24
KR860002450A (ko) 1986-04-26
ES8706610A1 (es) 1987-07-01
DK439285A (da) 1986-03-29
HUT40613A (en) 1987-01-28
CS264332B2 (en) 1989-07-12
DK167117B1 (da) 1993-08-30
SU1433409A3 (ru) 1988-10-23
NZ213628A (en) 1989-03-29
HU199774B (en) 1990-03-28
ES547283A0 (es) 1987-07-01
JPS6183147A (ja) 1986-04-26
AR242776A1 (es) 1993-05-31
JPH0517900B2 (de) 1993-03-10
ZA857449B (en) 1986-06-25
RO93388A (ro) 1987-12-31
DK439285D0 (da) 1985-09-27
AU578737B2 (en) 1988-11-03

Similar Documents

Publication Publication Date Title
DE3682874D1 (de) Pyranoindolizinderivate und verfahren zu ihrer herstellung.
DE3577552D1 (de) Vitamin d-derivate und verfahren zu deren herstellung.
DE3782994D1 (de) Erythromycin-a-derivate und verfahren zu ihrer herstellung.
DE3580428D1 (de) Waessrige dispersion und verfahren zu ihrer herstellung.
DE3482823D1 (de) Dihydropyridin-derivate und verfahren zu ihrer herstellung.
DE3576500D1 (de) Carbostyrilverbindungen, diese enthaltende zubereitungen und verfahren zu ihrer herstellung.
DE3583912D1 (de) Feuchtigkeitsfuehler und verfahren zu dessen herstellung.
DE3878475D1 (de) Organopolysiloxanemulsion und verfahren zu ihrer herstellung.
DE3482258D1 (de) 2,2-difluorpropionsaeurederivate und verfahren zu ihrer herstellung.
DE3582466D1 (de) Aminoalkohol-derivate und verfahren zu ihrer herstellung.
DE3879335D1 (de) Trifluorbenzolverbindungen und verfahren zu ihrer herstellung.
DE3685013D1 (de) Amino-trifluormethylpyridinverbindung und verfahren zu ihrer herstellung.
DE3673515D1 (de) Gonatrien-derivate und verfahren zu ihrer herstellung.
DE3483098D1 (de) Nagellacke und verfahren zu deren herstellung.
DE3765181D1 (de) Isocarbacycline und verfahren zu ihrer herstellung.
DE3785694D1 (de) Thiophenderivate und verfahren zu ihrer herstellung.
DE3778517D1 (de) 7-brom-beta-carbolin-derivate und verfahren zu ihrer herstellung.
DE3574699D1 (de) Monocyclische bis-oxethylsulfonyl-aniline und verfahren zu ihrer herstellung.
DE3677259D1 (de) Chinazolinonverbindungen und verfahren zu ihrer herstellung.
PT81713A (de) Oeladjuvierte vaccine und verfahren zu ihrer herstellung
DE3578884D1 (de) Chinoloncarbonsaeure derivate und verfahren zu ihrer herstellung.
DE3584479D1 (de) Synthetisches fraipontit und verfahren zu seiner herstellung.
DE3777245D1 (de) Protein und verfahren zu dessen herstellung.
DE3672931D1 (de) Chinoloncarbonsaeurederivate und verfahren zu ihrer herstellung.
AT399879B (de) Dihydro-pyrimido-thiazin-derivate und verfahren zu ihrer herstellung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee